Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines

Affiliations

¹ Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
² Division of Urology, VCU Health, Richmond, VA, USA.
³ Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
⁴ Departments of Urology and Epidemiology & Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, USA.
⁵ Unit of Urology, Ospedale ASST Sette Laghi, Varese, Italy.
⁶ Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
⁷ Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, MI, USA; Division of Urology, Spectrum Health Hospital System, Grand Rapids, MI, USA.
⁸ Section of Pathological Anatomy, Polytechnic University of the Marche Region, United Hospitals, Ancona, Italy.
⁹ Department of Urology, Ludwig-Maximilians University of Munich, Munich, Germany.
¹⁰ Service d'Urologie, Cliniques universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.
¹¹ Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: montorsi.francesco@hsr.it.

Umberto Capitanio et al. Eur Urol Oncol. 2022 Apr.

. 2022 Apr;5(2):256-258.

doi: 10.1016/j.euo.2021.03.005. Epub 2021 Apr 1.

¹ Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
² Division of Urology, VCU Health, Richmond, VA, USA.
³ Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
⁴ Departments of Urology and Epidemiology & Biostatistics, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, USA.
⁵ Unit of Urology, Ospedale ASST Sette Laghi, Varese, Italy.
⁶ Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
⁷ Department of Surgery, Michigan State University College of Human Medicine, Grand Rapids, MI, USA; Division of Urology, Spectrum Health Hospital System, Grand Rapids, MI, USA.
⁸ Section of Pathological Anatomy, Polytechnic University of the Marche Region, United Hospitals, Ancona, Italy.
⁹ Department of Urology, Ludwig-Maximilians University of Munich, Munich, Germany.
¹⁰ Service d'Urologie, Cliniques universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.
¹¹ Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy; Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: montorsi.francesco@hsr.it.

No abstract available

Comment in

Incidental Prostate Cancer: A Real Need for Expansion in Guidelines?
Mottet N, Rouviere O, van der Kwast TH. Mottet N, et al. Eur Urol Oncol. 2022 Apr;5(2):259-260. doi: 10.1016/j.euo.2021.04.006. Epub 2021 May 18. Eur Urol Oncol. 2022. PMID: 34020930 No abstract available.
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited.
Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane BR, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F. Capitanio U, et al. Eur Urol Oncol. 2022 Apr;5(2):261-262. doi: 10.1016/j.euo.2021.05.004. Epub 2021 Jun 1. Eur Urol Oncol. 2022. PMID: 34083164 No abstract available.